PETALING JAYA: BIG Caring Group has formed a strategic partnership with Taiwan’s leading pharmacy chain, Great Tree Pharmacy, and Japan’s 100-year-old health brand, B&S Corporation.
The collaboration marks a major milestone in building a win-win ecosystem for Asia’s health and wellness industry.
The partnership aims to introduce clinically proven, science-backed health products to markets across Asia by combining the group’s extensive retail pharmacy network with Great Tree Pharmacy’s market-leading expertise and B&S Corp’s advanced health research and stringent quality standards.
It reflects the shared commitment of three leading health industry players across Malaysia, Taiwan and Japan, united by a shared mission to advance preventive healthcare and provide consumers in Asia with safer, more professional and trusted health solutions.
BIG Caring Group CEO Lee Meng Chuan said the company’s mission has always been to expand access to trusted, high-quality healthcare solutions for every community it serves.
“We believe preventive healthcare is the future of wellness. By combining our collective strengths – Japan’s century-old health expertise, Taiwan’s market-leading pharmacy excellence, and our extensive pharmacy network – we are building a shared pathway to bring clinically proven, science-backed innovations to consumers across Asia,“ he said in a statement.
BIG Caring Group is Malaysia’s largest pharmacy chain, comprising BIG Pharmacy, Caring Pharmacy, Georgetown Pharmacy, Ting Pharmacy and Wellings Pharmacy.
As the first milestone of this alliance, the three partners jointly announced that Lactis, Japan’s renowned century-old postbiotic brand, will officially enter the Malaysian health supplement market this month.
Following this, more clinically supported and scientifically formulated Japanese products, including Japan’s most clinically validated anti-ageing and senior wellness supplements, will be gradually introduced to Malaysian consumers.
Since 2024, BIG Caring Group and Great Tree Pharmacy have collaborated to introduce the globally patented red yeast product Ankascin568, which has since garnered strong consumer acceptance.
Building on this success, the addition of Japan’s B&S Corporation elevates this cooperation from a product-level partnership into a whole strategic alliance, marking the start of a new phase in integrated supply chain and retail development across Asia.
This partnership represents a pivotal moment for Asia’s health industry. It signifies the beginning of a new era of cross-border collaboration, in which leading health brands from Malaysia, Taiwan and Japan create multi-win outcomes for both the healthcare sector and consumers.
Together, they strive to advance preventive healthcare and help shape a healthier, safer and internationally benchmarked healthcare ecosystem across Asia.
